Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut PIK3R1 5295 broad.mit.edu 37 5 67569270 67569270 + Silent SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr5:67569270G>A ENST00000521381.1 + 3 1003 c.387G>A c.(385-387)ccG>ccA p.P129P PIK3R1_ENST00000274335.5_Silent_p.P129P|PIK3R1_ENST00000396611.1_Silent_p.P129P|PIK3R1_ENST00000521657.1_Silent_p.P129P NM_181523.2 NP_852664.1 P27986 P85A_HUMAN phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 129 Rho-GAP. epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway 1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex 1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding p.?(2)|p.0?(1) breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2) 178 Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176) OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211) Isoproterenol(DB01064) ACATTGCCCCGCCTCTTCTTA 0.443000 """Mis, F, O""" """gliobastoma, ovarian, colorectal""" TCGA GBM(4;<1E-08) 24 223 0 0 1 0 0 RYR3 6263 broad.mit.edu 37 15 33893721 33893721 + Silent SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr15:33893721C>G ENST00000389232.4 + 17 1960 c.1890C>G c.(1888-1890)ctC>ctG p.L630L RYR3_ENST00000415757.3_Silent_p.L630L NM_001036.3 NP_001027.3 Q15413 RYR3_HUMAN ryanodine receptor 3 630 B30.2/SPRY 1. cellular calcium ion homeostasis integral to membrane calcium ion binding|receptor activity|ryanodine-sensitive calcium-release channel activity NS(3)|breast(9)|central_nervous_system(8)|cervix(2)|endometrium(29)|haematopoietic_and_lymphoid_tissue(2)|kidney(18)|large_intestine(55)|lung(148)|ovary(7)|pancreas(1)|prostate(13)|skin(4)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(3) 311 all_lung(180;7.18e-09) all cancers(64;8.95e-12)|GBM - Glioblastoma multiforme(186;0.00109)|BRCA - Breast invasive adenocarcinoma(123;0.0363) GAAACCTACTCCTGCAGACAC 0.512000 23 24 0 0 1 0 0 RB1CC1 9821 broad.mit.edu 37 8 53570054 53570054 + Missense_Mutation SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr8:53570054C>T ENST00000025008.5 - 15 2858 c.2335G>A c.(2335-2337)Gat>Aat p.D779N RB1CC1_ENST00000521611.1_Intron|RB1CC1_ENST00000435644.2_Missense_Mutation_p.D779N|RB1CC1_ENST00000539297.1_Missense_Mutation_p.D779N NM_014781.4 NP_055596.3 Q8TDY2 RBCC1_HUMAN RB1-inducible coiled-coil 1 779 autophagy|cell cycle|regulation of transcription, DNA-dependent|transcription, DNA-dependent cytosol|nucleus|pre-autophagosomal structure|ULK1-ATG13-FIP200 complex protein binding NS(2)|cervix(2)|endometrium(6)|kidney(4)|large_intestine(9)|lung(19)|ovary(8)|prostate(3)|skin(4)|stomach(1)|upper_aerodigestive_tract(2) 60 all_cancers(86;0.137)|all_epithelial(80;0.00494)|Lung NSC(129;0.011)|all_lung(136;0.023) ACATTTGTATCCTGCATTCGT 0.403000 33 85 0 0 1 0 0 KRTAP5-3 387266 broad.mit.edu 37 11 1629152 1629152 + Missense_Mutation SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr11:1629152C>G ENST00000399685.1 - 1 541 c.464G>C c.(463-465)tGc>tCc p.C155S NM_001012708.2 NP_001012726.1 Q6L8H2 KRA53_HUMAN keratin associated protein 5-3 155 11 X 4 AA repeats of C-C-X-P. keratin filament endometrium(1)|large_intestine(2)|lung(3)|ovary(2) 8 all_epithelial(84;0.00018)|Ovarian(85;0.0014)|Breast(177;0.00147)|Medulloblastoma(188;0.0109)|all_neural(188;0.0299)|Lung NSC(207;0.229) BRCA - Breast invasive adenocarcinoma(625;0.000618)|Lung(200;0.0684)|LUSC - Lung squamous cell carcinoma(625;0.0822) GGACTGGGAGCAGCTGGGCTT 0.627000 6 224 0 0 1 0 0 APLNR 187 broad.mit.edu 37 11 57003348 57003348 + Silent SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr11:57003348A>G ENST00000606794.1 - 1 1327 c.1131T>C c.(1129-1131)ctT>ctC p.L377L NM_005161.4 NP_005152.1 P35414 APJ_HUMAN apelin receptor 377 integral to plasma membrane G-protein coupled receptor activity breast(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(14)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1) 32 AGTCAACCACAAGGGTCTCCT 0.612000 22 34 0 0 1 0 0 RARS2 57038 broad.mit.edu 37 6 88239302 88239302 + Missense_Mutation SNP A A C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:88239302A>C ENST00000369536.5 - 10 881 c.836T>G c.(835-837)gTc>gGc p.V279G NM_020320.3 NP_064716.2 Q5T160 SYRM_HUMAN arginyl-tRNA synthetase 2, mitochondrial 279 arginyl-tRNA aminoacylation mitochondrial matrix arginine-tRNA ligase activity|ATP binding|protein binding breast(1)|central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(1)|large_intestine(6)|lung(7)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1) 22 all_cancers(76;3.93e-06)|Acute lymphoblastic leukemia(125;3.55e-10)|Prostate(29;3.51e-09)|all_hematologic(105;3.29e-06)|all_epithelial(107;0.00575) BRCA - Breast invasive adenocarcinoma(108;0.0456) CAACTTTAAGACCTCTTGAGA 0.308000 17 48 0 0 1 0 0 PCYOX1 51449 broad.mit.edu 37 2 70504434 70504434 + Silent SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:70504434C>T ENST00000433351.2 + 6 1456 c.1428C>T c.(1426-1428)aaC>aaT p.N476N PCYOX1_ENST00000264441.5_3'UTR|PCYOX1_ENST00000545138.1_Silent_p.N398N|PCYOX1_ENST00000505044.2_Silent_p.N399N NM_016297.3 NP_057381.3 Q9UHG3 PCYOX_HUMAN prenylcysteine oxidase 1 476 prenylated protein catabolic process lysosome|very-low-density lipoprotein particle prenylcysteine oxidase activity breast(1)|central_nervous_system(3)|endometrium(1)|kidney(1)|large_intestine(3)|lung(6) 15 CAGCCCACAACGCTGCACTCC 0.468000 15 256 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7578457 7578457 + Missense_Mutation SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:7578457C>T ENST00000420246.2 - 5 605 c.473G>A c.(472-474)cGc>cAc p.R158H TP53_ENST00000413465.2_Missense_Mutation_p.R158H|TP53_ENST00000455263.2_Missense_Mutation_p.R158H|TP53_ENST00000445888.2_Missense_Mutation_p.R158H|TP53_ENST00000269305.4_Missense_Mutation_p.R158H|TP53_ENST00000359597.4_Missense_Mutation_p.R158H NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 158 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. R -> C (in sporadic cancers; somatic mutation).|R -> F (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|R -> G (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> H (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in a sporadic cancer; somatic mutation).|R -> S (in sporadic cancers; somatic mutation).|R -> Y (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R158L(77)|p.R158H(74)|p.R158P(9)|p.R65L(8)|p.0?(8)|p.R26L(8)|p.R158fs(6)|p.R158fs*11(6)|p.R65H(5)|p.R26H(5)|p.R158_A159insX(4)|p.R65fs(2)|p.R158_A159delRA(2)|p.R156_I162delRVRAMAI(2)|p.V157fs*9(2)|p.P153fs*22(2)|p.R26fs(2)|p.V157fs*22(2)|p.V157_C176del20(1)|p.R156_A161delRVRAMA(1)|p.R158F(1)|p.P151_V173del23(1)|p.R156_R158delRVR(1)|p.R156fs*18(1)|p.R26fs*11(1)|p.R156_A161del(1)|p.V157_M160delVRAM(1)|p.V157_R158delVR(1)|p.S149fs*72(1)|p.A159fs*21(1)|p.T155_A161delTRVRAMA(1)|p.G154fs*22(1)|p.R65fs*11(1)|p.R156fs*20(1)|p.R158C(1)|p.V157_I162delVRAMAI(1)|p.V157fs*21(1)|p.R158fs*8(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GGCCATGGCGCGGACGCGGGT 0.627000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 49 65 0 0 1 0 0 UST 10090 broad.mit.edu 37 6 149340328 149340328 + Silent SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:149340328A>G ENST00000367463.4 + 6 838 c.735A>G c.(733-735)ttA>ttG p.L245L NM_005715.2 NP_005706.1 Q9Y2C2 UST_HUMAN uronyl-2-sulfotransferase 245 protein sulfation Golgi membrane|integral to membrane sulfotransferase activity breast(1)|endometrium(3)|large_intestine(4)|lung(2)|ovary(2) 12 Ovarian(120;0.0907) OV - Ovarian serous cystadenocarcinoma(155;1.78e-10)|GBM - Glioblastoma multiforme(68;0.138) ACCCCAGGTTATTTTACATCA 0.463000 5 173 0 0 1 0 0 TENM3 55714 broad.mit.edu 37 4 183609326 183609326 + Silent SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr4:183609326T>C ENST00000511685.1 + 12 2166 c.2043T>C c.(2041-2043)tgT>tgC p.C681C TENM3_ENST00000406950.2_Silent_p.C681C|TENM3_ENST00000502950.1_3'UTR teneurin transmembrane protein 3 TAGAAATATGTTCTGTGGACT 0.527000 58 92 0 0 1 0 0 GPC4 2239 broad.mit.edu 37 X 132458383 132458383 + Silent SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chrX:132458383G>A ENST00000370828.3 - 3 1025 c.501C>T c.(499-501)cgC>cgT p.R167R GPC4_ENST00000535467.1_Silent_p.R97R NM_001448.2 NP_001439.2 O75487 GPC4_HUMAN glypican 4 167 anatomical structure morphogenesis|cell proliferation anchored to membrane|external side of plasma membrane|extracellular space|insoluble fraction|integral to plasma membrane|proteinaceous extracellular matrix heparan sulfate proteoglycan binding breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(16)|skin(1)|upper_aerodigestive_tract(1) 28 Acute lymphoblastic leukemia(192;0.000127) GCTCCAGGAGGCGAGCCCAGA 0.468000 21 84 0 0 1 0 0 RAMP3 10268 broad.mit.edu 37 7 45222924 45222924 + Silent SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr7:45222924C>T ENST00000242249.4 + 3 398 c.360C>T c.(358-360)atC>atT p.I120I RAMP3_ENST00000496212.1_Silent_p.I120I|RAMP3_ENST00000481345.1_Silent_p.I120I NM_005856.2 NP_005847.1 O60896 RAMP3_HUMAN receptor (G protein-coupled) activity modifying protein 3 120 intracellular protein transport|receptor-mediated endocytosis|regulation of G-protein coupled receptor protein signaling pathway integral to plasma membrane|lysosome protein transporter activity breast(1)|endometrium(1)|large_intestine(4)|lung(4)|stomach(1) 11 Pramlintide(DB01278) AGGTTCTCATCCCGCTGATCG 0.632000 13 230 0 0 1 0 0 TFAP2D 83741 broad.mit.edu 37 6 50696680 50696680 + Missense_Mutation SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:50696680G>A ENST00000008391.3 + 4 938 c.710G>A c.(709-711)cGc>cAc p.R237H TFAP2D_ENST00000492804.1_3'UTR NM_172238.3 NP_758438.2 Q7Z6R9 AP2D_HUMAN transcription factor AP-2 delta (activating enhancer binding protein 2 delta) 237 DNA binding|sequence-specific DNA binding transcription factor activity NS(1)|biliary_tract(1)|breast(1)|central_nervous_system(1)|endometrium(4)|kidney(1)|large_intestine(12)|lung(26)|ovary(6)|pancreas(1)|prostate(5)|stomach(1) 60 Lung NSC(77;0.0334) GTAAAGAGGCGCCTCTCCCCA 0.473000 6 103 0 0 1 0 0 FABP2 2169 broad.mit.edu 37 4 120243252 120243252 + Silent SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr4:120243252C>T ENST00000274024.3 - 1 293 c.6G>A c.(4-6)gcG>gcA p.A2A NM_000134.3 NP_000125.2 P12104 FABPI_HUMAN fatty acid binding protein 2, intestinal 2 fatty acid binding breast(1)|large_intestine(4)|lung(1)|ovary(1)|pancreas(1) 8 TGCTGTCAAACGCCATGATTT 0.398000 7 253 0 0 1 0 0 DNAH9 1770 broad.mit.edu 37 17 11795176 11795176 + Missense_Mutation SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:11795176A>G ENST00000262442.3 + 58 11263 c.11195A>G c.(11194-11196)gAc>gGc p.D3732G DNAH9_ENST00000396001.2_Missense_Mutation_p.D44G|DNAH9_ENST00000454412.2_Missense_Mutation_p.D3732G NM_001372.3 NP_001363.2 Q9NYC9 DYH9_HUMAN dynein, axonemal, heavy chain 9 3732 cell projection organization|cellular component movement|microtubule-based movement|spermatogenesis axonemal dynein complex|cilium axoneme|cytoplasm|microtubule ATP binding|ATPase activity|microtubule motor activity NS(2)|autonomic_ganglia(1)|breast(15)|central_nervous_system(5)|endometrium(17)|haematopoietic_and_lymphoid_tissue(6)|kidney(17)|large_intestine(49)|liver(2)|lung(123)|ovary(6)|pancreas(1)|prostate(6)|skin(21)|stomach(2)|upper_aerodigestive_tract(13)|urinary_tract(4) 290 Breast(5;0.0122)|all_epithelial(5;0.131) Colorectal(4;6.88e-05)|COAD - Colon adenocarcinoma(4;0.000813)|READ - Rectum adenocarcinoma(10;0.157) AACCTAATAGACAGCATAACC 0.542000 6 170 0 0 1 0 0 VPS13D 55187 broad.mit.edu 37 1 12461735 12461735 + Silent SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr1:12461735T>C ENST00000358136.3 + 62 11989 c.11859T>C c.(11857-11859)ttT>ttC p.F3953F VPS13D_ENST00000496628.1_3'UTR|VPS13D_ENST00000356315.4_Silent_p.F3928F NM_015378.2 NP_056193.2 Q5THJ4 VP13D_HUMAN vacuolar protein sorting 13 homolog D (S. cerevisiae) 3952 protein localization NS(1)|breast(6)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(28)|lung(44)|ovary(5)|pancreas(1)|prostate(8)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(4) 130 Ovarian(185;0.249) Lung NSC(185;4.08e-05)|all_lung(284;4.55e-05)|Renal(390;0.000147)|Colorectal(325;0.00058)|Breast(348;0.00093)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255) UCEC - Uterine corpus endometrioid carcinoma (279;0.0327)|Colorectal(212;4.63e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000289)|COAD - Colon adenocarcinoma(227;0.000801)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0476)|Lung(427;0.209) TAAGTTTCTTTGGCTACGATC 0.373000 38 54 0 0 1 0 0 KRTAP10-12 386685 broad.mit.edu 37 21 46117134 46117134 + Silent SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr21:46117134C>T ENST00000400365.3 + 1 48 c.18C>T c.(16-18)agC>agT p.S6S TSPEAR_ENST00000323084.4_Intron NM_198699.1 NP_941972.1 P60413 KR10C_HUMAN keratin associated protein 10-12 6 keratin filament large_intestine(1)|lung(8) 9 TCTGCTCCAGCGACCTGAGCT 0.642000 27 166 0 0 1 0 0 ANKRD20A11P 0 broad.mit.edu 37 21 15326405 15326405 + RNA SNP C C T rs8127713 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr21:15326405C>T ENST00000344693.5 - 0 802 NR_027270.1 TTTCCATTGACTATTCTGTTT 0.423000 4 89 0 0 1 0 0 PRKDC 5591 broad.mit.edu 37 8 48706915 48706915 + Missense_Mutation SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr8:48706915T>C ENST00000314191.2 - 75 10659 c.10603A>G c.(10603-10605)Agc>Ggc p.S3535G PRKDC_ENST00000338368.3_Missense_Mutation_p.S3535G|PRKDC_ENST00000523565.1_5'UTR NM_006904.6 NP_008835.5 P78527 PRKDC_HUMAN protein kinase, DNA-activated, catalytic polypeptide 3536 FAT. cellular response to insulin stimulus|double-strand break repair via nonhomologous end joining|peptidyl-serine phosphorylation|positive regulation of transcription from RNA polymerase II promoter DNA-dependent protein kinase-DNA ligase 4 complex|transcription factor complex ATP binding|DNA binding|DNA-dependent protein kinase activity|transcription factor binding NS(1)|autonomic_ganglia(1)|breast(2)|central_nervous_system(9)|cervix(3)|endometrium(15)|haematopoietic_and_lymphoid_tissue(2)|kidney(6)|large_intestine(30)|lung(56)|ovary(6)|pancreas(1)|prostate(8)|skin(7) 147 all_cancers(86;0.0336)|all_epithelial(80;0.00111)|Lung NSC(129;0.00363)|all_lung(136;0.00391) CTTTCGCTGCTTATGATGAAG 0.423000 Non-homologous end-joining 9 14 0 0 1 0 0 LILRA4 23547 broad.mit.edu 37 19 54850418 54850418 + Translation_Start_Site SNP G G A rs35407007 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr19:54850418G>A ENST00000291759.4 - 0 3 NM_012276.3 NP_036408.3 P59901 LIRA4_HUMAN leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 integral to membrane receptor activity NS(2)|breast(1)|central_nervous_system(2)|endometrium(2)|large_intestine(5)|lung(13)|prostate(3)|skin(1)|upper_aerodigestive_tract(3) 32 Ovarian(34;0.19) GBM - Glioblastoma multiforme(193;0.0565) CACGGTGCCCGTAGACACAGA 0.597000 3 25 0 0 1 0 0 TPTE2P6 0 broad.mit.edu 37 13 25168432 25168432 + RNA SNP T T C rs149337771 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr13:25168432T>C ENST00000453498.1 + 0 1104 TTGAAACAGCTGGTGTATTAA 0.373000 4 37 0 0 1 0 0 FOXP2 93986 broad.mit.edu 37 7 114270000 114270000 + Silent SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr7:114270000G>A ENST00000393500.3 + 11 1132 c.312G>A c.(310-312)caG>caA p.Q104Q FOXP2_ENST00000350908.4_Silent_p.Q179Q|FOXP2_ENST00000390668.3_Silent_p.Q203Q|AC020606.1_ENST00000580664.1_RNA|FOXP2_ENST00000360232.4_Silent_p.Q179Q|FOXP2_ENST00000393489.3_Silent_p.Q87Q|FOXP2_ENST00000393498.2_Silent_p.Q159Q|FOXP2_ENST00000393491.3_Silent_p.Q87Q|FOXP2_ENST00000408937.3_Silent_p.Q204Q|FOXP2_ENST00000393494.2_Silent_p.Q179Q|FOXP2_ENST00000403559.4_Silent_p.Q196Q|FOXP2_ENST00000378237.3_Silent_p.Q179Q O15409 FOXP2_HUMAN forkhead box P2 179 Gln-rich. camera-type eye development|caudate nucleus development|cerebellum development|cerebral cortex development|embryo development|growth|lung alveolus development|negative regulation of transcription, DNA-dependent|pattern specification process|positive regulation of epithelial cell proliferation involved in lung morphogenesis|positive regulation of mesenchymal cell proliferation|post-embryonic development|putamen development|regulation of sequence-specific DNA binding transcription factor activity|righting reflex|skeletal muscle tissue development|smooth muscle tissue development|vocal learning cytoplasm|transcription factor complex chromatin binding|DNA bending activity|double-stranded DNA binding|promoter binding|protein heterodimerization activity|protein homodimerization activity|sequence-specific DNA binding|sequence-specific enhancer binding RNA polymerase II transcription factor activity|specific RNA polymerase II transcription factor activity|specific transcriptional repressor activity|transcription activator activity|transcription factor binding|zinc ion binding p.Q204Q(1) breast(3)|endometrium(7)|kidney(4)|large_intestine(7)|lung(22)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 52 agcaacaacagcagcagcagc 0.498000 4 33 0 0 1 0 0 GRM7 2917 broad.mit.edu 37 3 7620372 7620372 + Silent SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr3:7620372T>C ENST00000486284.1 + 8 2053 c.1779T>C c.(1777-1779)atT>atC p.I593I GRM7_ENST00000402647.2_Silent_p.I593I|GRM7_ENST00000403881.1_Silent_p.I593I|GRM7_ENST00000458641.2_3'UTR|GRM7_ENST00000357716.4_Silent_p.I593I|GRM7_ENST00000389336.4_Silent_p.I593I NM_181874.2 NP_870989.1 Q14831 GRM7_HUMAN glutamate receptor, metabotropic 7 593 negative regulation of adenylate cyclase activity|negative regulation of cAMP biosynthetic process|negative regulation of glutamate secretion|sensory perception of smell|sensory perception of sound|synaptic transmission asymmetric synapse|axon|cell cortex|dendritic shaft|integral to plasma membrane|postsynaptic membrane|presynaptic active zone adenylate cyclase inhibitor activity|calcium ion binding|glutamate binding|group III metabotropic glutamate receptor activity|PDZ domain binding|serine binding breast(2)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(14)|lung(35)|ovary(4)|prostate(2)|skin(6)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2) 76 L-Glutamic Acid(DB00142) GGGCTGTGATTCCTGTCTTCC 0.552000 10 117 0 0 1 0 0 DEFB113 245927 broad.mit.edu 37 6 49936551 49936551 + Missense_Mutation SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:49936551C>T ENST00000398718.1 - 2 87 c.88G>A c.(88-90)Gag>Aag p.E30K NM_001037729.1 NP_001032818.1 Q30KQ7 DB113_HUMAN defensin, beta 113 30 defense response to bacterium extracellular region breast(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(2)|lung(3) 7 Lung NSC(77;0.042) CTTTTTCTCTCTGCAACTTCT 0.383000 3 26 0 0 1 0 0 SIGLEC11 114132 broad.mit.edu 37 19 50464040 50464040 + Missense_Mutation SNP G G A rs148651187 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr19:50464040G>A ENST00000447370.2 - 2 319 c.229C>T c.(229-231)Cgg>Tgg p.R77W SIGLEC11_ENST00000426971.2_Missense_Mutation_p.R77W NM_052884.2 NP_443116.2 Q96RL6 SIG11_HUMAN sialic acid binding Ig-like lectin 11 77 Ig-like V-type. cell adhesion integral to membrane sugar binding breast(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(8)|lung(9)|ovary(6)|pancreas(1)|prostate(1)|skin(1) 32 all_lung(116;0.00318)|all_neural(266;0.107)|Ovarian(192;0.17) GBM - Glioblastoma multiforme(134;0.00107)|OV - Ovarian serous cystadenocarcinoma(262;0.00517) GGGCTGGTCCGTCCTTTGAAC 0.607000 3 30 0 0 1 0 0 TFCP2L1 29842 broad.mit.edu 37 2 121997207 121997207 + Missense_Mutation SNP C C T rs141932688 byFrequency TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:121997207C>T ENST00000263707.5 - 8 884 c.787G>A c.(787-789)Gtg>Atg p.V263M NM_014553.2 NP_055368.1 Q9NZI6 TF2L1_HUMAN transcription factor CP2-like 1 263 female pregnancy|steroid biosynthetic process mitochondrion|nucleolus DNA binding|sequence-specific DNA binding transcription factor activity|transcription corepressor activity cervix(1)|endometrium(4)|large_intestine(5)|lung(7)|ovary(1)|pancreas(2)|skin(1)|stomach(1) 22 Renal(3;0.01) TGGTAGGCCACGTCGGGCCAT 0.632000 4 76 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113112 209113112 + Missense_Mutation SNP C C T rs121913500 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:209113112C>T ENST00000415913.1 - 4 776 c.395G>A c.(394-396)cGt>cAt p.R132H IDH1_ENST00000446179.1_Missense_Mutation_p.R132H|IDH1_ENST00000345146.2_Missense_Mutation_p.R132H O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132H(2774)|p.R132L(59)|p.R132V(1)|p.G131_R132>VL(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) ATAAGCATGACGACCTATGAT 0.393000 Mis gliobastoma 35 66 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7577121 7577121 + Missense_Mutation SNP G G A rs121913343 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:7577121G>A ENST00000420246.2 - 8 949 c.817C>T c.(817-819)Cgt>Tgt p.R273C TP53_ENST00000413465.2_Intron|TP53_ENST00000455263.2_Missense_Mutation_p.R273C|TP53_ENST00000445888.2_Missense_Mutation_p.R273C|TP53_ENST00000269305.4_Missense_Mutation_p.R273C|TP53_ENST00000359597.4_Missense_Mutation_p.R273C NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 273 Interaction with AXIN1 (By similarity).|Interaction with DNA.|Interaction with E4F1.|Interaction with HIPK1 (By similarity). R -> C (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> G (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> H (in LFS; germline mutation and in sporadic cancers; somatic mutation; abolishes sequence-specific DNA binding; dbSNP:rs28934576).|R -> L (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> N (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in sporadic cancers; somatic mutation).|R -> S (in a familial cancer not matching LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> Y (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R273C(481)|p.R273S(16)|p.R273G(9)|p.0?(8)|p.?(2)|p.R273fs*72(2)|p.R273fs*33(2)|p.R273fs*32(2)|p.V272>?(2)|p.F270fs*72(1)|p.R273_C275delRVC(1)|p.L265_K305del41(1)|p.S269fs*21(1)|p.E258fs*71(1)|p.R273fs*71(1)|p.F270_D281del12(1)|p.E271_R273delEVR(1)|p.V272_K292del21(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) GCACAAACACGCACCTCAAAG 0.542000 R273C(8MGBA_CENTRAL_NERVOUS_SYSTEM)|R273C(BL70_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(EFO27_OVARY)|R273C(KARPAS299_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(MFE319_ENDOMETRIUM)|R273C(NCIH1048_LUNG)|R273C(PANC0213_PANCREAS)|R273C(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(RDES_BONE)|R273C(RH30_SOFT_TISSUE)|R273C(RPMI8402_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SH10TC_STOMACH)|R273C(SJRH30_SOFT_TISSUE)|R273C(SUDHL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R273C(SW1710_URINARY_TRACT)|R273C(SW1783_CENTRAL_NERVOUS_SYSTEM)|R273C(TT2609C02_THYROID) 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 11 13 0 0 1 0 0 AC008103.5 0 broad.mit.edu 37 22 18844763 18844763 + RNA SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr22:18844763T>C ENST00000412938.1 + 0 3013 TCACAGCCTCTGAGGGCAGCA 0.562000 5 8 0 0 1 0 0 ACOT9 23597 broad.mit.edu 37 X 23748659 23748659 + Missense_Mutation SNP G G T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chrX:23748659G>T ENST00000379303.5 - 6 513 c.385C>A c.(385-387)Ctt>Att p.L129I ACOT9_ENST00000336430.7_Missense_Mutation_p.L120I|ACOT9_ENST00000492081.1_Missense_Mutation_p.L60I|ACOT9_ENST00000379295.1_Missense_Mutation_p.L60I NM_001037171.1 NP_001032248.1 Q9Y305 ACOT9_HUMAN acyl-CoA thioesterase 9 120 acyl-CoA metabolic process mitochondrion acetyl-CoA hydrolase activity|carboxylesterase activity breast(1)|kidney(1)|large_intestine(4)|lung(3)|ovary(4)|pancreas(1)|skin(1) 15 AAGCTGTCAAGATCCTCAAGA 0.343000 37 12 2.43139e-17 2.52144e-17 1 1 0 HMHA1 23526 broad.mit.edu 37 19 1085938 1085938 + Missense_Mutation SNP C C T rs146748497 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr19:1085938C>T ENST00000313093.2 + 23 3575 c.3344C>T c.(3343-3345)cCc>cTc p.P1115L HMHA1_ENST00000539243.2_Missense_Mutation_p.P1131L|HMHA1_ENST00000590577.1_Missense_Mutation_p.P750L|HMHA1_ENST00000590214.1_Missense_Mutation_p.P1142L|HMHA1_ENST00000591169.1_3'UTR|HMHA1_ENST00000543365.1_Missense_Mutation_p.P998L|HMHA1_ENST00000536472.1_Missense_Mutation_p.P983L|HMHA1_ENST00000586866.1_Missense_Mutation_p.P1119L NM_012292.3 NP_036424.2 Q92619 HMHA1_HUMAN histocompatibility (minor) HA-1 1115 regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction cytosol GTPase activator activity|metal ion binding NS(1)|central_nervous_system(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|lung(7)|ovary(1)|prostate(2) 16 Acute lymphoblastic leukemia(61;2.53e-14)|all_hematologic(61;8.18e-10)|Lung NSC(49;1.04e-05)|all_lung(49;1.53e-05)|Breast(49;9.42e-05)|Hepatocellular(1079;0.137) UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|STAD - Stomach adenocarcinoma(1328;0.18) CCACTGCCCCCCATGAGGCTC 0.682000 10 191 0 0 1 0 0 SLC9A2 6549 broad.mit.edu 37 2 103324661 103324661 + Missense_Mutation SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:103324661C>G ENST00000233969.2 + 12 2294 c.2152C>G c.(2152-2154)Cag>Gag p.Q718E NM_003048.3 NP_003039.2 Q9UBY0 SL9A2_HUMAN solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 718 integral to membrane|plasma membrane sodium:hydrogen antiporter activity breast(5)|central_nervous_system(3)|endometrium(3)|kidney(1)|large_intestine(3)|lung(17)|prostate(1)|skin(5)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 42 CTTGCCAGAACAGTTCTCCAA 0.537000 26 126 0 0 1 0 0 TPTE2P6 0 broad.mit.edu 37 13 25168501 25168501 + RNA SNP G G A rs4770716 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr13:25168501G>A ENST00000453498.1 + 0 1173 TTTTCTCTTCGGTGAGTAATC 0.388000 4 44 0 0 1 0 0 BACH2 60468 broad.mit.edu 37 6 90661005 90661005 + Nonsense_Mutation SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:90661005G>A ENST00000257749.4 - 7 1527 c.820C>T c.(820-822)Cag>Tag p.Q274* RP3-512E2.2_ENST00000445838.1_RNA|RP3-512E2.2_ENST00000413986.1_RNA|BACH2_ENST00000343122.3_Nonsense_Mutation_p.Q274*|BACH2_ENST00000537989.1_Nonsense_Mutation_p.Q274* NM_021813.2 NP_068585.1 Q9BYV9 BACH2_HUMAN BTB and CNC homology 1, basic leucine zipper transcription factor 2 274 nucleus protein dimerization activity|sequence-specific DNA binding central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(8)|lung(18)|ovary(5)|pancreas(1)|prostate(1)|skin(3)|urinary_tract(1) 45 all_cancers(76;7.37e-06)|Acute lymphoblastic leukemia(125;2.23e-10)|Prostate(29;5.55e-10)|all_hematologic(105;2.42e-06)|all_epithelial(107;0.0063) BRCA - Breast invasive adenocarcinoma(108;0.0799) CTTTTAATCTGCCCCCTGGCA 0.532000 46 58 0 0 1 0 0 DEFB112 245915 broad.mit.edu 37 6 50011409 50011409 + Missense_Mutation SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:50011409T>C ENST00000322246.4 - 2 220 c.221A>G c.(220-222)tAc>tGc p.Y74C NM_001037498.1 NP_001032587.1 Q30KQ8 DB112_HUMAN defensin, beta 112 74 defense response to bacterium extracellular region central_nervous_system(1)|large_intestine(3)|lung(12)|ovary(1)|skin(1)|upper_aerodigestive_tract(1) 19 Lung NSC(77;0.042) TCTTGCACAGTATGAAATCCT 0.433000 34 67 0 0 1 0 0 SLC7A2 6542 broad.mit.edu 37 8 17396342 17396342 + Missense_Mutation SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr8:17396342A>G ENST00000470360.1 + 3 126 c.9A>G c.(7-9)atA>atG p.I3M SLC7A2_ENST00000398090.3_Missense_Mutation_p.I3M|SLC7A2_ENST00000522656.1_Intron|SLC7A2_ENST00000494857.1_Intron|SLC7A2_ENST00000004531.10_Missense_Mutation_p.I3M P52569 CTR2_HUMAN solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 0 cellular amino acid metabolic process|ion transport cytoplasm|integral to plasma membrane|membrane fraction basic amino acid transmembrane transporter activity breast(1)|central_nervous_system(1)|endometrium(3)|kidney(4)|large_intestine(4)|lung(8)|ovary(2)|skin(1)|stomach(1) 25 Colorectal(111;0.0577)|COAD - Colon adenocarcinoma(73;0.216) L-Lysine(DB00123)|L-Ornithine(DB00129) GAATGAAGATAGAAACAAGTG 0.388000 17 62 0 0 1 0 0 SF3A3 10946 broad.mit.edu 37 1 38435137 38435137 + Splice_Site SNP C C A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr1:38435137C>A ENST00000373019.4 - 14 2126 c.e14-1 SF3A3_ENST00000448721.2_Splice_Site NM_006802.2 NP_006793.1 Q12874 SF3A3_HUMAN splicing factor 3a, subunit 3, 60kDa nuclear mRNA 3'-splice site recognition catalytic step 2 spliceosome|nuclear speck nucleic acid binding|protein binding|zinc ion binding breast(1)|endometrium(1)|kidney(3)|large_intestine(1)|liver(1)|lung(3)|prostate(2) 12 Acute lymphoblastic leukemia(166;0.074)|all_hematologic(146;0.197) Myeloproliferative disorder(586;0.0255) AGGGAATAGGCTAAAAAAGAA 0.418000 15 34 3.27435e-08 3.33389e-08 1 1 0 UBBP4 0 broad.mit.edu 37 17 21730847 21730847 + Missense_Mutation SNP G G T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:21730847G>T ENST00000584755.1 + 2 546 c.149G>T c.(148-150)cGg>cTg p.R50L UBBP4_ENST00000583708.1_Intron|UBBP4_ENST00000584398.1_Intron|UBBP4_ENST00000578713.1_Missense_Mutation_p.R50L endometrium(9)|kidney(4)|lung(4)|prostate(3)|urinary_tract(4) 24 GGCAAGCAGCGGGAAGATGGC 0.522000 3 46 0.115264 0.115264 1 1 0 KRT81 3887 broad.mit.edu 37 12 52680930 52680930 + Silent SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr12:52680930G>A ENST00000327741.5 - 7 1271 c.1203C>T c.(1201-1203)atC>atT p.I401I KRT86_ENST00000544024.1_Intron|KRT86_ENST00000423955.2_Intron NM_002281.3 NP_002272.2 Q14533 KRT81_HUMAN keratin 81 401 Coil 2.|Rod. keratin filament protein binding|structural molecule activity breast(2)|endometrium(3)|large_intestine(3)|lung(6)|prostate(1)|stomach(1) 16 BRCA - Breast invasive adenocarcinoma(357;0.189) TGGCGATCTCGATGTCCAGGC 0.647000 5 106 0 0 1 0 0 TPTE2P6 0 broad.mit.edu 37 13 25168489 25168489 + RNA SNP G G A rs142860004 by1000genomes TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr13:25168489G>A ENST00000453498.1 + 0 1161 TGAAAGTGCAGTTTTTCTCTT 0.363000 4 48 0 0 1 0 0 TTN 7273 broad.mit.edu 37 2 179655479 179655479 + Missense_Mutation SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:179655479C>G ENST00000589042.1 - 11 1980 c.1756G>C c.(1756-1758)Gaa>Caa p.E586Q TTN_ENST00000360870.5_Missense_Mutation_p.E586Q|TTN_ENST00000460472.2_Intron|TTN_ENST00000359218.5_Intron|TTN_ENST00000342992.6_Missense_Mutation_p.E586Q|TTN_ENST00000591111.1_Missense_Mutation_p.E586Q|TTN_ENST00000342175.6_Intron NM_001267550.1 NP_001254479.1 Q8WZ42 TITIN_HUMAN titin 586 ATP binding|nucleic acid binding|protein serine/threonine kinase activity|protein tyrosine kinase activity NS(24)|autonomic_ganglia(1)|breast(64)|central_nervous_system(14)|cervix(14)|endometrium(96)|haematopoietic_and_lymphoid_tissue(16)|kidney(91)|large_intestine(303)|liver(1)|lung(595)|ovary(58)|pancreas(17)|prostate(38)|skin(60)|stomach(29)|upper_aerodigestive_tract(1)|urinary_tract(26) 1448 OV - Ovarian serous cystadenocarcinoma(117;0.023)|Epithelial(96;0.0454)|all cancers(119;0.134) GTGGTAGTTTCTTCTTGAGCT 0.423000 6 149 0 0 1 0 0 RAP1GAP2 23108 broad.mit.edu 37 17 2909299 2909299 + Silent SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:2909299C>T ENST00000254695.8 + 16 1413 c.1323C>T c.(1321-1323)aaC>aaT p.N441N RAP1GAP2_ENST00000540393.2_Silent_p.N422N|RAP1GAP2_ENST00000366401.4_Silent_p.N426N|RAP1GAP2_ENST00000542807.1_Silent_p.N441N NM_015085.4 NP_055900.4 Q684P5 RPGP2_HUMAN RAP1 GTPase activating protein 2 441 Rap-GAP. regulation of small GTPase mediated signal transduction centrosome|cytosol|perinuclear region of cytoplasm GTPase activator activity endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|lung(2)|ovary(1)|upper_aerodigestive_tract(1) 11 ATGCCGAGAACGCCTGCTGCA 0.572000 5 148 0 0 1 0 0 DOPEY1 23033 broad.mit.edu 37 6 83855297 83855297 + Missense_Mutation SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr6:83855297A>G ENST00000349129.2 + 25 5856 c.5596A>G c.(5596-5598)Atc>Gtc p.I1866V DOPEY1_ENST00000369739.3_Missense_Mutation_p.I1857V|DOPEY1_ENST00000484282.1_3'UTR|DOPEY1_ENST00000237163.5_Missense_Mutation_p.I1847V NM_015018.3 NP_055833.2 Q5JWR5 DOP1_HUMAN dopey family member 1 1866 protein transport breast(4)|central_nervous_system(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(15)|lung(16)|ovary(5)|pancreas(1)|prostate(1)|skin(5)|upper_aerodigestive_tract(2) 67 all_cancers(76;2.29e-06)|Acute lymphoblastic leukemia(125;3.41e-06)|all_hematologic(105;0.000865)|all_epithelial(107;0.00203) BRCA - Breast invasive adenocarcinoma(397;0.053) GGTTCGTTCAATCAGTGTCAT 0.373000 15 26 0 0 1 0 0 FMR1 2332 broad.mit.edu 37 X 147010283 147010283 + Missense_Mutation SNP T T C TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chrX:147010283T>C ENST00000218200.8 + 5 606 c.377T>C c.(376-378)tTc>tCc p.F126S FMR1_ENST00000370475.4_Missense_Mutation_p.F126S|FMR1_ENST00000370470.1_Missense_Mutation_p.F126S|FMR1_ENST00000334557.6_Missense_Mutation_p.F126S|FMR1_ENST00000370477.1_Missense_Mutation_p.F126S|FMR1_ENST00000439526.2_Missense_Mutation_p.F126S|FMR1_ENST00000370471.3_Missense_Mutation_p.F126S NM_001185076.1|NM_001185082.1 NP_001172005.1|NP_001172011.1 Q06787 FMR1_HUMAN fragile X mental retardation 1 126 mRNA transport|negative regulation of translational initiation cytoplasm|mRNA cap binding complex|nucleolus|nucleoplasm|soluble fraction mRNA binding|protein binding NS(1)|breast(1)|endometrium(7)|kidney(1)|large_intestine(8)|lung(13)|ovary(2)|pancreas(1)|upper_aerodigestive_tract(1) 35 Acute lymphoblastic leukemia(192;6.56e-05) AAAGATACTTTCCATAAGATC 0.368000 Fragile X syndrome 10 63 0 0 1 0 0 COL9A2 1298 broad.mit.edu 37 1 40782860 40782860 + Missense_Mutation SNP C C T TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr1:40782860C>T ENST00000372748.3 - 1 106 c.10G>A c.(10-12)Gct>Act p.A4T NM_001852.3 NP_001843.1 Q14055 CO9A2_HUMAN collagen, type IX, alpha 2 4 axon guidance|skeletal system development collagen type IX endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(5)|ovary(4)|stomach(2)|urinary_tract(2) 22 Lung NSC(20;4.38e-06)|Ovarian(52;0.00167)|all_hematologic(146;0.0501)|Acute lymphoblastic leukemia(166;0.074) Myeloproliferative disorder(586;0.0255) OV - Ovarian serous cystadenocarcinoma(33;2.08e-17) GAGGCCGTAGCGGCGGCCATG 0.701000 9 4 0 0 1 0 0 ASPSCR1 79058 broad.mit.edu 37 17 79943447 79943447 + Missense_Mutation SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:79943447C>G ENST00000306729.7 + 4 435 c.338C>G c.(337-339)aCc>aGc p.T113S ASPSCR1_ENST00000581647.1_Missense_Mutation_p.T113S|ASPSCR1_ENST00000306739.4_Missense_Mutation_p.T113S|ASPSCR1_ENST00000580534.1_Missense_Mutation_p.T36S NM_001251888.1 NP_001238817.1 Q9BZE9 ASPC1_HUMAN alveolar soft part sarcoma chromosome region, candidate 1 113 protein binding ASPSCR1/TFE3(167) breast(2)|large_intestine(2) 4 all_neural(118;0.0878)|Ovarian(332;0.12)|all_lung(278;0.246) BRCA - Breast invasive adenocarcinoma(99;0.0114)|OV - Ovarian serous cystadenocarcinoma(97;0.0191) TCAGGCCAGACCCTCTGGGAG 0.542000 T TFE3 alveolar soft part sarcoma 4 80 0 0 1 0 0 NADSYN1 55191 broad.mit.edu 37 11 71166162 71166162 + Missense_Mutation SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr11:71166162A>G ENST00000319023.2 + 2 280 c.92A>G c.(91-93)gAa>gGa p.E31G NM_018161.4 NP_060631.2 Q6IA69 NADE_HUMAN NAD synthetase 1 31 CN hydrolase. NAD biosynthetic process|water-soluble vitamin metabolic process cytosol ATP binding|hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds|NAD+ synthase (glutamine-hydrolyzing) activity|protein binding breast(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(11)|ovary(2)|skin(2)|upper_aerodigestive_tract(1) 25 L-Glutamic Acid(DB00142)|L-Glutamine(DB00130) ACAGGTATTGAAATTGCCAAA 0.438000 18 40 0 0 1 0 0 UBXN7 26043 broad.mit.edu 37 3 196096372 196096372 + Missense_Mutation SNP T T A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr3:196096372T>A ENST00000296328.4 - 7 700 c.626A>T c.(625-627)gAc>gTc p.D209V UBXN7_ENST00000535858.1_Missense_Mutation_p.D61V|UBXN7_ENST00000428095.1_Missense_Mutation_p.D47V NM_015562.1 NP_056377.1 O94888 UBXN7_HUMAN UBX domain protein 7 209 protein binding NS(1)|endometrium(2)|large_intestine(4)|lung(6)|ovary(2)|pancreas(1)|prostate(1)|skin(1) 18 TTCCTCACTGTCATGATAAAC 0.363000 14 48 0 0 1 0 0 ZNF844 284391 broad.mit.edu 37 19 12187443 12187443 + Missense_Mutation SNP C C G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr19:12187443C>G ENST00000439326.3 + 4 1683 c.1508C>G c.(1507-1509)cCt>cGt p.P503R ZNF844_ENST00000441304.2_3'UTR NM_001136501.1 NP_001129973.1 Q08AG5 ZN844_HUMAN zinc finger protein 844 503 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding p.P503R(1) NS(1)|breast(2)|central_nervous_system(1)|endometrium(2)|kidney(2)|lung(1)|prostate(1) 10 GAGAGAAACCCTATGAGTGTA 0.413000 3 45 0 0 1 0 0 PIK3R1 5295 broad.mit.edu 37 5 67591086 67591086 + Missense_Mutation SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr5:67591086A>G ENST00000521381.1 + 13 2295 c.1679A>G c.(1678-1680)gAc>gGc p.D560G PIK3R1_ENST00000274335.5_Missense_Mutation_p.D560G|PIK3R1_ENST00000320694.8_Missense_Mutation_p.D260G|PIK3R1_ENST00000396611.1_Missense_Mutation_p.D560G|PIK3R1_ENST00000523872.1_Missense_Mutation_p.D197G|PIK3R1_ENST00000521657.1_Missense_Mutation_p.D560G|PIK3R1_ENST00000336483.5_Missense_Mutation_p.D290G NM_181523.2 NP_852664.1 P27986 P85A_HUMAN phosphoinositide-3-kinase, regulatory subunit 1 (alpha) 560 epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|growth hormone receptor signaling pathway|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|interspecies interaction between organisms|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of establishment of protein localization in plasma membrane|positive regulation of glucose import|T cell costimulation|T cell receptor signaling pathway 1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex 1-phosphatidylinositol binding|ErbB-3 class receptor binding|insulin binding|insulin receptor binding|insulin receptor substrate binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase regulator activity|protein phosphatase binding p.D560_S565del(1)|p.R557_K561>Q(1)|p.0?(1)|p.?(1) breast(12)|central_nervous_system(31)|cervix(1)|endometrium(68)|haematopoietic_and_lymphoid_tissue(5)|kidney(1)|large_intestine(32)|lung(10)|ovary(9)|pancreas(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(2) 178 Lung NSC(167;1.99e-05)|Prostate(74;0.00308)|Ovarian(174;0.00473)|Colorectal(97;0.0176) OV - Ovarian serous cystadenocarcinoma(47;3.76e-51)|Lung(70;0.0211) Isoproterenol(DB01064) CGAGAAATTGACAAACGTATG 0.358000 """Mis, F, O""" """gliobastoma, ovarian, colorectal""" TCGA GBM(4;<1E-08) 24 89 0 0 1 0 0 CDH23 64072 broad.mit.edu 37 10 73548698 73548698 + Splice_Site SNP A A G TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr10:73548698A>G ENST00000224721.6 + 44 5842 c.5835_splice c.e44-1 p.D1946_splice NM_022124.5 NP_071407.4 Q9H251 CAD23_HUMAN cadherin-related 23 1941 Cadherin 18. calcium ion transport|calcium-dependent cell-cell adhesion|cytosolic calcium ion homeostasis|equilibrioception|homophilic cell adhesion|photoreceptor cell maintenance|response to stimulus|sensory perception of sound cytosol|integral to membrane|plasma membrane|stereocilium calcium ion binding|protein binding NS(1)|breast(2)|central_nervous_system(6)|endometrium(15)|haematopoietic_and_lymphoid_tissue(5)|kidney(7)|large_intestine(27)|lung(49)|ovary(3)|pancreas(1)|prostate(7)|stomach(7)|upper_aerodigestive_tract(3) 133 CCCTTGCAGGATTATGACTTG 0.547000 14 25 0 0 1 0 0 KIAA0556 23247 broad.mit.edu 37 16 27786309 27786309 + Silent SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr16:27786309G>A ENST00000261588.4 + 24 4372 c.4353G>A c.(4351-4353)gtG>gtA p.V1451V NM_015202.2 NP_056017.2 O60303 K0556_HUMAN KIAA0556 1451 breast(4)|endometrium(7)|kidney(8)|large_intestine(17)|lung(24)|ovary(5)|prostate(3)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(3) 76 TGGAGGGTGTGGGCGGGGACG 0.627000 14 75 0 0 1 0 0 CRHBP 1393 broad.mit.edu 37 5 76264637 76264637 + Missense_Mutation SNP G G A TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr5:76264637G>A ENST00000274368.4 + 7 1318 c.896G>A c.(895-897)cGt>cAt p.R299H CRHBP_ENST00000514258.1_Intron NM_001882.3 NP_001873.2 P24387 CRHBP_HUMAN corticotropin releasing hormone binding protein 299 female pregnancy|learning or memory|signal transduction soluble fraction kidney(3)|large_intestine(4)|lung(6)|prostate(1)|skin(2) 16 all_lung(232;0.000414)|Lung NSC(167;0.0011)|Ovarian(174;0.0129)|Prostate(461;0.11) OV - Ovarian serous cystadenocarcinoma(54;2.17e-51)|Epithelial(54;8.79e-46)|all cancers(79;2.49e-41) TTTGAGTATCGTCAGCTGGAG 0.458000 18 58 0 0 1 0 0 ARHGEF10L 55160 broad.mit.edu 37 1 17944985 17944987 + In_Frame_Del DEL CCT CCT - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr1:17944985_17944987delCCT ENST00000375408.3 + 1 175_177 c.137_139delCCT c.(136-141)ccc>c p.PS46del ARHGEF10L_ENST00000375415.1_Intron|ARHGEF10L_ENST00000375420.3_Intron|ARHGEF10L_ENST00000361221.3_Intron|ARHGEF10L_ENST00000452522.1_Intron|ARHGEF10L_ENST00000434513.1_Intron|ARHGEF10L_ENST00000469726.1_Intron|ARHGEF10L_ENST00000167825.4_In_Frame_Del_p.PS46del Q9HCE6 ARGAL_HUMAN Rho guanine nucleotide exchange factor (GEF) 10-like 0 regulation of Rho protein signal transduction cytoplasm Rho guanyl-nucleotide exchange factor activity NS(1)|breast(1)|central_nervous_system(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(5)|liver(2)|lung(16)|ovary(4)|pancreas(1)|prostate(3)|skin(1)|upper_aerodigestive_tract(1) 43 Colorectal(325;3.46e-05)|Breast(348;0.000162)|all_lung(284;0.000337)|Lung NSC(340;0.000419)|Renal(390;0.000518)|Ovarian(437;0.00409)|Myeloproliferative disorder(586;0.0255) UCEC - Uterine corpus endometrioid carcinoma (279;0.00598)|COAD - Colon adenocarcinoma(227;1.62e-05)|BRCA - Breast invasive adenocarcinoma(304;1.68e-05)|Kidney(64;0.000269)|KIRC - Kidney renal clear cell carcinoma(64;0.00361)|STAD - Stomach adenocarcinoma(196;0.00656)|READ - Rectum adenocarcinoma(331;0.0718)|Lung(427;0.204) ATCCGCTGTCcctcctcctcctc 0.680 2 4 --- --- --- --- ASXL2 55252 broad.mit.edu 37 2 26022304 26022306 + In_Frame_Del DEL CTG CTG - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr2:26022304_26022306delCTG ENST00000435504.4 - 5 644_646 c.351_353delCAG c.(349-354)agt>ag p.SS117del ASXL2_ENST00000497092.1_5'UTR|ASXL2_ENST00000272341.4_5'UTR|ASXL2_ENST00000336112.4_In_Frame_Del_p.SS89del Q76L83 ASXL2_HUMAN additional sex combs like 2 (Drosophila) 117 Ser-rich. regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus metal ion binding|protein binding NS(1)|breast(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(4)|lung(7)|pancreas(1)|prostate(4)|skin(3)|urinary_tract(3) 33 Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215) GCCACCATCACTGCTGCTGCTGC 0.463 9 205 --- --- --- --- MKRN1 23608 broad.mit.edu 37 7 140154921 140154922 + Frame_Shift_Del DEL TC TC - rs1062780 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr7:140154921_140154922delTC ENST00000255977.2 - 7 1433_1434 c.1209_1210delGA c.(1207-1212)caaafs p.QK403fs MKRN1_ENST00000437223.2_Frame_Shift_Del_p.QK137fs|MKRN1_ENST00000474576.1_Frame_Shift_Del_p.QK339fs NM_013446.3 NP_038474.2 Q9UHC7 MKRN1_HUMAN makorin ring finger protein 1 403 ligase activity|nucleic acid binding|protein binding|zinc ion binding endometrium(1)|kidney(1)|large_intestine(3)|lung(9)|ovary(1)|skin(1) 16 Melanoma(164;0.00956) GTTCCCACTTTCTGTCTCTGTG 0.485 80 187 --- --- --- --- ZMIZ1 57178 broad.mit.edu 37 10 81072446 81072446 + Frame_Shift_Del DEL C C - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr10:81072446delC ENST00000334512.5 + 25 3716 c.3144delC c.(3142-3144)gafs p.D1048fs ZMIZ1_ENST00000446377.2_Frame_Shift_Del_p.D114fs NM_020338.3 NP_065071.1 Q9ULJ6 ZMIZ1_HUMAN zinc finger, MIZ-type containing 1 1048 transcription, DNA-dependent cytoplasm|nuclear speck zinc ion binding breast(1)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(5)|lung(14)|ovary(2)|prostate(3)|skin(1) 30 all_cancers(46;0.0292)|Breast(12;8.52e-05)|all_epithelial(25;0.000854)|Prostate(51;0.00985) Epithelial(14;0.00256)|all cancers(16;0.00726)|Colorectal(32;0.229) CTTATCTGGACCCCCCCGACC 0.557 7 413 --- --- --- --- RP13-516M14.2 0 broad.mit.edu 37 17 80173535 80173535 + RNA DEL C C - rs112012232 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr17:80173535delC ENST00000581303.1 + 0 1371 tccttccctgccccccacact 0.701 4 4 --- --- --- --- RP4-777D9.2 0 broad.mit.edu 37 20 21142442 21142442 + RNA DEL A A - rs113752643 TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr20:21142442delA ENST00000591761.1 - 0 5142 PLK1S1_ENST00000457464.1_RNA|RP5-872K7.7_ENST00000425746.2_RNA TCATTTCTGGAAAAAAAAAAA 0.363 2 4 --- --- --- --- L3MBTL1 26013 broad.mit.edu 37 20 42143378 42143378 + Frame_Shift_Del DEL C C - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr20:42143378delC ENST00000444063.1 + 1 326 c.194delC c.(193-195)gcfs p.A65fs L3MBTL1_ENST00000457824.1_3'UTR|L3MBTL1_ENST00000418998.1_Frame_Shift_Del_p.A133fs|L3MBTL1_ENST00000373135.3_Frame_Shift_Del_p.A65fs|L3MBTL1_ENST00000373134.1_Frame_Shift_Del_p.A65fs|L3MBTL1_ENST00000427442.2_Frame_Shift_Del_p.A133fs Q9Y468 LMBL1_HUMAN l(3)mbt-like 1 (Drosophila) 65 chromatin modification|hemopoiesis|negative regulation of transcription, DNA-dependent|regulation of megakaryocyte differentiation|regulation of mitosis chromatin|condensed chromosome|nucleoplasm identical protein binding|methylated histone residue binding|nucleosomal histone binding|SAM domain binding|sequence-specific DNA binding transcription factor activity|zinc ion binding breast(1)|large_intestine(3)|ovary(1)|skin(2) 7 GATGGCGGGGCCCCGGCGGGA 0.721 2 4 --- --- --- --- DBNDD2 55861 broad.mit.edu 37 20 44038638 44038640 + In_Frame_Del DEL CCT CCT - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chr20:44038638_44038640delCCT ENST00000372712.2 + 4 925_927 c.344_346delCCT c.(343-348)acc>a p.TS115del DBNDD2_ENST00000372720.3_In_Frame_Del_p.TS213del|DBNDD2_ENST00000372722.3_3'UTR|DBNDD2_ENST00000357275.2_In_Frame_Del_p.TS115del|DBNDD2_ENST00000360981.4_In_Frame_Del_p.TS115del|SYS1-DBNDD2_ENST00000452133.1_3'UTR|DBNDD2_ENST00000372717.1_3'UTR|DBNDD2_ENST00000372710.3_In_Frame_Del_p.TS217del|SYS1-DBNDD2_ENST00000475242.1_3'UTR|DBNDD2_ENST00000372723.3_In_Frame_Del_p.TS115del Q9BQY9 DBND2_HUMAN dysbindin (dystrobrevin binding protein 1) domain containing 2 213 negative regulation of protein kinase activity cytoplasm protein binding breast(1)|lung(2) 3 Myeloproliferative disorder(115;0.0122) ACATCTAGGAcctcctcctcctc 0.567 3 4 --- --- --- --- ATRX 546 broad.mit.edu 37 X 76939473 76939474 + Frame_Shift_Del DEL TT TT - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chrX:76939473_76939474delTT ENST00000373344.5 - 9 1488_1489 c.1274_1275delAA c.(1273-1275)afs p.K425fs ATRX_ENST00000395603.3_Frame_Shift_Del_p.K387fs|ATRX_ENST00000480283.1_5'UTR NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 425 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TATTTTTCTCTTTGTTTACAGC 0.361 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 79 35 --- --- --- --- PCDH19 57526 broad.mit.edu 37 X 99663560 99663562 + In_Frame_Del DEL CAG CAG - TCGA-FG-8188-01A-11D-2253-08 TCGA-FG-8188-10A-01D-2253-08 Untested Somatic Phase_I WXS none Illumina GAIIx 4fec960b-9288-453a-8c65-5b3e04b61550 c145c9e4-6e4d-4f21-a264-4bbb8a82930a g.chrX:99663560_99663562delCAG ENST00000373034.4 - 1 1709_1711 c.34_36delCTG c.(34-36)del p.L12del PCDH19_ENST00000420881.2_In_Frame_Del_p.L12del|PCDH19_ENST00000255531.7_In_Frame_Del_p.L12del NM_001184880.1 NP_001171809.1 Q8TAB3 PCD19_HUMAN protocadherin 19 12 homophilic cell adhesion integral to membrane|plasma membrane calcium ion binding breast(5)|endometrium(11)|kidney(1)|large_intestine(14)|liver(1)|lung(23)|ovary(3)|prostate(2)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(2) 68 ACAGTATGGCCAGCAGCAGCAGC 0.665 2 4 --- --- --- ---